ROIVANT SCIENCES LTD. Payments for Repurchase of Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ROIVANT SCIENCES LTD. payments for repurchase of equity for the quarter ending 2022-12-31 was $0.00.
- ROIVANT SCIENCES LTD. payments for repurchase of equity for the quarter ending 2022-09-30 was -$8.33M, a 470.67% decline year-over-year.
- ROIVANT SCIENCES LTD. payments for repurchase of equity for the quarter ending 2022-06-30 was $8.33M.
- ROIVANT SCIENCES LTD. payments for repurchase of equity for the quarter ending 2021-12-31 was $0.00.
| Period end | Payments for Repurchase of Equity 3 month | Payments for Repurchase of Equity 12 month |
|---|---|---|
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-13 | |
| 2022-09-30 | -$8.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | |
| 2022-06-30 | $8.33M 10-Q · filed 2022-08-15 | |
| 2021-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-13 | |
| 2021-09-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | |
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14 | |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | |
| 2020-06-30 | $113.00K 10-Q · filed 2021-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |